SEC Form 4 · accession 0001179110-15-010524
CymaBay Therapeutics, Inc. · CBAY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kirk Rosemark
Officer — V.P. Regulatory & Quality
Period of report
Jun 24, 2015
Accepted (ET)
Jun 30, 2015 · 6:09 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001042074
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $2.97 | Jun 24, 2015 | A | 37,500 | A | — | Jun 24, 2025 | Common Stock | 37,500 | 37,500 | D |
Explanation of responses
- F1The option vests with respect to 25% of the underlying shares upon the first anniversary of the vesting commencement date of April 27, 2015, and then with respect to the remaining 75% of the underlying shares in 36 equal monthly installments.